April 24th 2025
New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
Study Assesses Amyloid PET/MRI Combination in Detection of Alzheimer’s Disease
July 15th 2024Emerging research revealed that a machine learning combination of amyloid beta PET and structural MRI demonstrated an 89 percent AUC in differentiating between older healthy patients and those with Alzheimer’s disease.
Study: Use of Preoperative MRI 46 Percent Less Likely for Black Women with Breast Cancer
July 11th 2024In the study of over 1,400 women with breast cancer, researchers noted that Black women with dense breasts or lobular histology were significantly less likely to have preoperative MRI exams than White women with the same clinical characteristics.
Can AI Facilitate Effective Triage for Supplemental Breast MRI After Negative Mammography Screening?
July 10th 2024The AISmartDensity software facilitated a cancer detection rate (CDR) with breast MRI that was nearly four times higher than the CDR previously reported in trials involving traditional breast density assessment.
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
Can Brain MRI-Based Connectome Mapping Predict the Progression of Parkinson's Disease?
June 26th 2024For patients with mild Parkinson’s disease, new research suggests that indexes of disease pathology with structural and functional connectivity of brain regions can help predict progression of gray matter atrophy at two- and three-year follow-up brain MRI exams.
MRI Workflow Adjustments Lead to Nearly 35 Percent Decline in Exam Delays for Sedated Patients
June 20th 2024Targeting improvements in workflow, patient consent protocols and adherence to scheduled exam times, researchers noted significant reductions in 15-minute and 30-minute delays with MRI exams for patients who required sedation or general anesthesia.
Breast MRI Study: Can Node-RADS Scoring Enhance Detection of Lymph Node Invasion in Breast Cancer?
June 17th 2024Employing a cut-off of Node-RADS > 2 for differentiating malignant lymph nodes with breast MRI in women with breast cancer, researchers noted average sensitivity and specificity rates of 91.5 percent and 87.4 percent respectively.
Essential Keys to MRI Safety in the Age of Advanced Diagnostics
June 6th 2024As ongoing advances continue to redefine and elevate the diagnostic capabilities of MRI, ensuring the safety of patients and operators through effective signage, training and regular safety audits is of paranount importance.
Abbreviated Breast MRI and Dense Breasts: What Emerging Research Reveals
May 22nd 2024In a study of over 2,000 women with dense breasts and average breast cancer risk, abbreviated MRI (AB-MR) demonstrated an 18.9 per 1000 cancer detection rate (CDR) in baseline exams, and all cancers detected with baseline or subsequent AB/MR exams were stage 0 or 1.